Older men with multiple sclerosis (MS) who use medicines that reduce the levels of androgens, or male sex hormones, experience sustained or increased disease activity instead of the expected decreases that typically happen with advancing age, a small study suggests. According to the team, such disease activity was “particularly”…
Read more
For many Americans, the July 4 holiday is a joyful celebration filled with fireworks, barbecues, parades, and time spent outdoors with family and friends. However, for me, it can present unique challenges due to my multiple sclerosis (MS). From heat sensitivity and sensory overload to difficulty participating in…
A new low-cost version of Tecfidera, a widely used oral therapy for relapsing forms of multiple sclerosis (MS), is now available in the U.S. for a fraction of the typical cost. Launched by Civicascript, this generic form of dimethyl fumarate is expected to significantly improve access to…
Trauma is not stress, and you can’t meditate your way out of it. I’d never considered this before. Of all the talks I attended last month at the Institute for Functional Medicine’s annual conference in San Diego, the one that has stayed with me most as someone living…
A new imaging technology may help detect early signs of brain damage in people with multiple sclerosis (MS) that aren’t visible on conventional MRI scans, a recent study shows. The technology detects specific metabolic alterations in the brain by tracking certain metabolites and neurotransmitters — molecules that nerve…
Get regular updates to your inbox.
